[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07293936":3,"trial-entities:NCT07293936":97,"trial-summary:NCT07293936":100},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":22,"study_type":28,"primary_purpose":14,"phases":29,"enrollment_info":31,"interventions":34,"primary_outcomes":44,"secondary_outcomes":49,"sex":58,"minimum_age":59,"maximum_age":60,"healthy_volunteers":15,"eligibility_criteria":61,"std_ages":67,"locations":70,"central_contacts":86,"overall_officials":94,"references":95,"see_also_links":96},"NCT07293936","202412294","Post-Filter Hematocrit","Validation of a Post-Filter Hematocrit Calculation Formula: A Comparative Analysis With Measured Post-Filter Hematocrit Values","RECRUITING","2026-03-15","2025-12","2025-12-19","2025-03-15","Gwyndolyn M. Radford","OTHER",false,"Filter clotting is a major complication of continuous renal replacement therapy (CRRT), resulting in blood loss, reduced treatment efficacy, and increased cost. One modifiable factor associated with filter clotting is filtration fraction (FF), or the proportion of plasma water being removed from the blood over the course of the filter. In convention, a cutoff of FF\\\u003C20-30% has been used to prevent hemofilter clotting, but no evidence correlating FF with hemofilter clotting has been documented. Some experts have proposed that post-filter hematocrit (Hct) could be a more direct marker for determining hemofilter clotting risk, but evidence supporting clinical utility of this marker is lacking.\n\nHCTpost=HCTpre\u002F(FF(HCTpre-1)+1)\n\nIn our proposed validation study, we hope to determine whether our formula for post-filter Hct provides accurate results when compared to measured values. The information obtained from this study will potentially justify the use of utilizing the formula in future studies.\n\nThe procedure of this study is collecting blood samples from the post-filter lines of patients on CRRT at different time points and different flow rates. This will be considered the \"measured post-filter hematocrit\" which will then be compared to the calculated formula above, using the other values obtained from daily labs (for pre-filter hematocrit) and CRRT machine settings.","This investigational study is listed as \"other\" because it is a validation study comparing two measurement methods-comparing a calculated versus a machine-measured post-filter hematocrit- and is typically classified as a cross-sectional investigational study in the context of diagnostic or method comparison research.",[19,20,21],"Continuous Renal Replacement Therapy","Renal Failure","Hemofilter Clotting",[23,24,25,26,27],"crrt","continuous renal replacement therapy","hemofilter clotting","post-filter hematocrit","filtration fraction","INTERVENTIONAL",[30],"NA",{"count":32,"type":33},20,"ESTIMATED",[35,40],{"type":14,"name":36,"description":37,"armGroupLabels":38},"Calculated Post-Filter Hematocrit","using the formula: HCTpost=HCTpre\u002F(FF(HCTpre-1)+1)",[39],"CRRT patients",{"type":14,"name":41,"description":42,"armGroupLabels":43},"Measured Post-Filter Hematocrit","Measured from blood sample taken from CRRT machine",[39],[45],{"measure":46,"description":47,"timeFrame":48},"Agreement between measured and calculated post-filter hematocrit values.","Use Bland-Altman analysis to assess agreement and quantify bias and limits of agreement. Calculate correlation coefficients (Pearson or Spearman) to evaluate the strength of association.","Participation begins at consent and includes a single study procedure in which four post-filter blood samples are collected over ~40 minutes. Participation ends after the final draw. Generally, no longer than 1 day.",[50,54],{"measure":51,"description":52,"timeFrame":53},"Analyze the impact of CRRT settings on discrepancies between measured and calculated Filtration Fraction","How do different settings (e.g., Q\\_B, Q\\_UF, Q\\_prefilter, Q\\_postfilter) on the machine affect the discrepancies (if there are any) between calculated and measured filtration fraction. Will be using change in post-filter hematocrit values as the measured filtration fraction and comparing to calculated filtration fraction using standard flow-rate derived formula used in practice.","Participation begins at consent and includes a single study procedure in which four post-filter blood samples are collected over ~40 minutes. Participation ends after the final draw. Generally, no longer than one day.",{"measure":55,"description":56,"timeFrame":57},"Subgroup analysis based on patient-specific factors","Post-filter hematocrit values will be stratified and compared across subgroups defined by baseline pre-filter hematocrit category, anticoagulation strategy (e.g., citrate vs. heparin vs. none), and blood-flow rate category. The metric reported will be the mean post-filter hematocrit within each subgroup and the between-group differences.","Participation begins at consent and includes a single study procedure in which four post-filter blood samples are collected over ~40 minutes. Participation ends after the final draw.","ALL","18 Years",null,{"inclusion":62,"exclusion":64,"raw_text":66},[63],"patients initiated on CRRT age equal than or greater to 18 years of age",[65],"patients on ECMO","Inclusion Criteria:\n\n* patients initiated on CRRT age equal than or greater to 18 years of age\n\nExclusion Criteria:\n\n* patients on ECMO",[68,69],"ADULT","OLDER_ADULT",[71],{"facility":72,"status":8,"city":73,"state":74,"zip":75,"country":76,"contacts":77,"geoPoint":83},"University of Iowa Hospitals and Clinics","Iowa City","Iowa","52242","United States",[78],{"name":79,"role":80,"phone":81,"email":82},"Gwyndolyn M Radford, MD","CONTACT","319-384-9668","gwyndolyn-radford@uiowa.edu",{"lat":84,"lon":85},41.66113,-91.53017,[87,90],{"name":79,"role":80,"phone":88,"email":89},"7858179620","gradford@uiowa.edu",{"name":91,"role":80,"phone":92,"email":93},"Benjamin R Griffin, MD","5073631404","benjamin-griffin@uiowa.edu",[],[],[],{"nct_id":4,"conditions":98,"biomarkers":99},[21,20],[],{"nct_id":4,"found":101,"summary":102,"prompt_version":112},true,{"design":103,"status":104,"heading":105,"summary":106,"follow_up":107,"word_count":108,"commitments":109,"compensation":110,"drugs_mentioned":111},"This is an interventional study comparing two measurement methods. It plans to include 20 participants.","completed","Comparing Post-Filter Hematocrit Measurements in CRRT","This study is for adults (18 and older) who are receiving continuous renal replacement therapy (CRRT) for kidney failure. Researchers are comparing two ways to measure \"post-filter hematocrit\" (Hct), which is the thickness of your blood after it goes through the CRRT filter. One way is by calculating it using a formula (Calculated Post-Filter Hematocrit), and the other is by taking a direct blood sample from the CRRT machine (Measured Post-Filter Hematocrit). The goal is to see how well these two methods agree. This is important because post-filter Hct might help doctors prevent filter clotting, a common problem with CRRT. The study aims to enroll 20 participants and is currently unclear on its recruitment status.","Participation ends after the final blood draw, generally no longer than 1 day.",115,"You would participate in a single study procedure where four post-filter blood samples are collected over about 40 minutes. Your participation ends after the final blood draw, generally within one day.","Not stated in the trial record.",[36,41],"v2"]